Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kronos Bio
Biotech
Ignota buys Kronos' pipeline to rescue shelved programs
Ignota has bagged more drugs for its rehabilitation scheme, snapping up Kronos' pipeline months after setbacks drove the biotech off public markets.
Nick Paul Taylor
Oct 6, 2025 5:45am
Concentra swoops in to purchase struggling Kronos
May 1, 2025 3:07pm
Time runs out for Kronos’ HQ amid wider cost-cutting push
Apr 11, 2025 7:20am
Kronos lays off 83% of staff, changes CEO after clinical setback
Nov 27, 2024 9:56am
Kronos shelves sole clinical drug over neurological side effects
Nov 14, 2024 5:14am
CRISPR Tx, Novartis, Cour & more—Chutes & Ladders
May 24, 2024 8:30am
